Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
De’Longhi: Hot or Cold?
Between navigating 16 chaotic and judgy dog roommates, Brad is just searching for his Perfetto cup of hot or cold coffee.
‘Masters of the Universe’ on Roblox
Roblox sends players on an ad-venture.
Eskiin
Send these marketing claims to the shower.
TINA.org Tells DOT: Don’t Muddy Airline Pricing
A proposed rule change could make it harder to know what you’ll actually pay for a flight.
Tinggly
TINA.org unwraps the hidden cost of these gift boxes.